Biomerica, Inc. (BMRA) vs Curanex Pharmaceuticals Inc Common Stock (CURX)
A side-by-side comparison of Biomerica, Inc. and Curanex Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRA
Biomerica, Inc.
$2.12HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
CURX
Curanex Pharmaceuticals Inc Common Stock
$5.08HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
Total return — BMRA vs CURX
growth of $100 · dividends reinvested · last 1yBMRA -39.9% (-39.9%/yr)CURX -93.8% (-93.8%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
BMRA CURX
BMRA vs CURX: by the numbers
- •CURX is the larger company ($7M vs $7M market cap).
- •Both run net losses; CURX's is the smaller (0.00% vs -84.79% net margin).
Metrics side by side
Valuation
| Metric | BMRA | CURX |
|---|---|---|
| P/S ratio | 1.47 | N/A |
| P/B ratio | 2.49 | 1.50 |
Profitability
| Metric | BMRA | CURX |
|---|---|---|
| Gross margin | 8.09% | 0.00% |
| Operating margin | -119.54% | 0.00% |
| Net margin | -84.79% | 0.00% |
| ROE | -143.54% | -218.65% |
| ROIC | -117.93% | -208.39% |
Growth (annualized)
| Metric | BMRA | CURX |
|---|---|---|
| Revenue CAGR (5Y) | -9.17% | N/A |
| Total return CAGR (5Y) | -46.66% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.